Camaisa Allan - Insider Non-Derivative Transactions at Calidi Biotherapeutics, Inc. (CLDI) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 26, 2024, Camaisa Allan's relationship to Calidi Biotherapeutics, Inc. (CLDI) is Director,Officer,TenPercentOwner (CEO and Chairman of the Board), and currently has 76,712 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CLDI insiders.

Data Source: SEC.
Camaisa Allan - Insider Non-Derivative Transactions of CLDI Common Stock
Camaisa Allan - Insider Non-Derivative Transactions at CLDI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 27, 2024 Acquisition -- (Common Stock) 70155 1.15 76712